(Q48700750)

14 February 2018

title

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. (English)

1 reference

14 February 2018

1 reference

1 reference

Miranda AF

1

1 reference

14 February 2018

Boegman RJ

series ordinal

2

1 reference

14 February 2018

Beninger RJ

series ordinal

3

1 reference

14 February 2018

Jhamandas K

series ordinal

4

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

number of pages

9

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

14 February 2018

volume

78

1 reference

14 February 2018

page(s)

967-975

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Glutamate receptors in the substantia nigra of Parkinson's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

The pharmacology of Parkinson's disease therapy: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Subtypes of excitatory amino acid receptors involved in the stimulation of [3H]dopamine release from cell cultures of rat ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Kynurenine pathway abnormalities in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Immunocytochemical localization of the quinolinic acid synthesizing enzyme, 3-hydroxyanthranilic acid oxygenase, in the rat substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

II. Excitotoxic models for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Kynurenic acid: a potential pathogen in brain disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Quinolinic acid and other kynurenines in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

A simple and sensitive fluorometric assay for tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

NMDA receptor involvement in two animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900655-0

7 January 2021

10.1016/S0306-4522(96)00655-0

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9174065

1 reference

14 February 2018